Cutler Group LP Gossamer Bio, Inc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Jul 18, 2023	BUY	$0.98 - $1.53 $4,998 - $7,803	5,100 New	5,100 $0
Q4 2022 Feb 07, 2023	BUY	$1.74 - $12.87 $20,184 - $149,292	11,600 Added 682.35%	13,300 $2,000
Q3 2022 Oct 25, 2022	BUY	$7.21 - $14.88 $12,257 - $25,296	1,700 New	1,700 $5,000
Q3 2021 Oct 26, 2021	SELL	$7.25 - $13.23 $21,750 - $39,690	-3,000 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$8.0 - $9.75 $24,000 - $29,250	3,000 New	3,000 $6,000
Q2 2020 Jul 22, 2020	SELL	$9.52 - $15.98 $14,280 - $23,970	-1,500 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$8.0 - $15.48 $32,000 - $61,920	-4,000 Reduced 72.73%	1,500 $5,000
Q4 2019 Feb 06, 2020	BUY	$14.82 - $26.79 $31,122 - $56,259	2,100 Added 61.76%	5,500 $10,000
Q3 2019 Oct 28, 2019	BUY	$16.02 - $22.47 $54,468 - $76,398	3,400 New	3,400 $3,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.